1. Tonjum T, Putten JV. Neisseria. In: Cohen J, Powderly WG, Opal SM, eds. Infectious Diseases. Fourth edition. Philadelphia, Elsevier; 2017.
2. Kılıç A, Başustaoğlu AC. Neisseria Türleri. Willke Topçu A, Söyletir G, Doğanay M, eds. Enfeksiyon Hastalıkları ve Mikrobiyolojisi. Sistemlere Göre Enfeksiyonlar. Dördüncü Baskı. Ankara,
Nobel Tıp Kitabevi, 2017.
3. Marrazzo JM, Apicella MA. Neisseria gonorrhoeae (Gonorrhea). In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principal and Practice of Infectious Diseases. 9 th
edition. Philadelphia, Elsevier; 2020.
4. Stephens DS. Neisseria meningitidis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principal and Practice of Infectious Diseases. 9 th edition. Philadelphia, Elsevier;
2020.
5. Elias J, Frosch M, Vogel U. Neisseria. In: Jorgensen JH, Pfaller MA, Carrol KC, Landry ML, Funke G, Richter SS, Warnock DW, eds. Manual of Clinical Microbiology. 11th edition. Washington
DC, ASM Press; 2015.
6. Gerçeker D. Neisseria ve İlişkili Cinsler. In: Murray PR, Rosenthal KS, Pfaller MA, eds. Çeviri Editörleri: US D, Başustaoğlu AC. Tıbbi Mikrobiyoloji. Yedinci Baskı. Ankara, Pelikan Kitabevi;
2016.
7. Kayacan Ç. Gram Negatif Koklar. Review of Medical Microbiology and Immunology. Warren Levinson, ed. Tıbbi Mikrobiyoloji ve İmmunoloji. Çeviri Editörleri. Şener B, Esen B. 14.Baskı.
Ankara, Güneş Tıp Kitapevi, 2018.
8. Liu G., Tang C.M., Exley R.M.: Non-pathogenic Neisseria: members of an abundant, multi-habitat, diverse genus. Microbiology 2015; 161: 1297-1312.
9. Ulusal Mikrobiyoloji Standartları, Bulaşıcı Hastalıklar Laboratuvar Tanı Rehberi. Gonorenin (Neisseria gonorrhoeae Enfeksiyonu) Mikrobiyolojik Tanısı. B-MT-17. Türkiye Halk Sağlığı Ku-
rumu, Sağlık Bakanlığı Yayın No: 934, ISBN 978-975-590-489-4, Ankara, 2014.
10. Sümerkan B. Neisseria gonorrhoeae Enfeksiyonlarında Patogenez. Editörler: Badur S, Abacıoğlu H, Öngen B. Enfeksiyon Patogenezi ve Bağışıklık. Ankara, Akademi Yayınevi; 2015.
11. McGee ZA, Jensen RL, Clemens CM, Taylor-Robinson D, Johnson AP, Gregg CR. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue
TNF-alpha concentration to sloughing of ciliated cells. Sex Transm Dis 1999; 26(3): 160-5.
12. CDC 2016 STD Surveillance Report; October 2017.
13. Bulaşıcı Hastalıklar Sürveyans ve Kontrol Esasları Yönetmeliğinde Değişiklik Yapılmasına Dair Yönetmelik. RG 22/04/2020-31107.
14. Ulusal Mikrobiyoloji Standartları, Sahada Çalışan Hekimler İçin Laboratuvar Rehberi. Gonore. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No: 964, ISBN 978-975-590-511-2, An-
kara, 2014.
15. Ulusal Mikrobiyoloji Standartları, Ulusal Biyogüvenlik Rehberi. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No: 937, ISBN 978-975-590-487-0, Ankara, 2014.
16. Gaydos CA, Van Der Pol B, Jett-Goheen M, et al. Performance of Cepheid CT/NG Xpert rapid PCR test for the detection of Chlamydiae trachomatis and Neisseria gonorrhoeae. J Clin Microbiol
2013; 51(6): 1666-72.
17. Dillon JA, Yeung KH. Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species. Clin Microbiol Rev 1989; 2(suppl): S125-S133.
18. Deguchi T, Yasuda M, Nakano M, et al. Quinolone resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV
with antimicrobial susceptibility profiles. Antimicrob Agents Chemother 1996; 40: 1020-1023.
19. Kirkcaldy RD, et al. MMWR Morb Mortal Wkly Rep. 2016; 65.
20. Bignell C, Unemo M. 2013. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2013; 24(2): 85-92.
21. Centers for Disease Control and Prevention. 2012. Up-date to CDC’s sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for
gonococcal infections. MMWR Morb Mortal Wkly Rep 2012; 61: 590-594.
22. Kirkcaldy RD, Hook EW, Soge OO, et al. Trends in Neisseria gonorrhoeae susceptibility to cephalosporins in the United States, 2006-2014. JAMA 2015; 314: 1869-1871.
23. Soge OO, Harger D, Schafer S, et al. Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011).
Sex Transm Dis 2012; 39:877–879.
24. MacNeil JR, Blain AE, Wang X, et al. Current epidemiology and trends in meningococcal disease-United States, 1996-2015. Clin Infect Dis 2018; 66:1276-1281.
25. Toneatto D, Pizza M, Masignani V, et al. Emerging experience with meningococcal serogroup B protein vaccines. Expert Rev Vaccines 2017; 16: 433-451.
26. Vipond C, Care R, Feavers IM. History of meningococcal vaccines and their serological correlates of protection. Vaccine 2012; 30 (suppl 2): B10-B17.
27. Stephens DS. Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics. Trans Am Clin Cli-
matol Assoc 2011; 122: 115-123.
28. Brandtzaeg P, van Deuren M. Classification and pathogenesis of meningococcal infections. Methods Mol Biol 2012; 799: 21-35.
29. Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 853-861.
30. Caugant DA, Martin CJ, Maiden M. Meningococcal carriage and disease – population biology and evolution. Vaccine 2009; 27: B64-B70.
31. Hill DJ, Virji M. Meningococcal ligands and molecular targets of the host. Methods Mol Biol 2012; 799: 143-152.
32. Breakwell L, Whaley M, Khan UI, et al. Meningococcal carriage among a university student population – United States, 2015. Vaccine 2018; 36(1):29-35.
33. Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007; 369: 2196-2210.
34. WHO, 2021. Defeating meningitis by 2030: A global road map. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
35. Aşı ile Önlenebilir İnvaziv Bakteriyel Hastalıklar Sürveyansı Genelgesi – Rehberi. Türkiye Halk Sağlığı Kurumu, 2016/23.
36. Enhancing sensitivity of qPCR assays targeting Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae by using a mutant Taq DNA polymerase. Nar Otgun S, Ketre
Kolukirik CZ, Unal Sahin N, Kolukirik M, Girgin Ozgumus G, Turan M, Elmas M, Kilic S. J Microbiol Methods 2024; 219: 106899. doi: 10.1016/j.mimet.2024.106899.
37. Mikrobiyoloji Standartları, Bulaşıcı Hastalıklar Laboratuvar Tanı Rehberi. Neisseria meningitidis Enfeksiyonlarının Mikrobiyolojik Tanısı. B-MT-03. Türkiye Halk Sağlığı Kurumu, Sağlık
Bakanlığı Yayın No: 934, ISBN 978-975-590-489-4, Ankara, 2014.
38. Ulusal Mikrobiyoloji Standartları, Sahada Çalışan Hekimler İçin Laboratuvar Rehberi. Meningokokkal Hastalık. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı Yayın No: 964, ISBN 978-975-
590-511-2, Ankara, 2014.
39. Centers for Disease Control and Prevention (CDC). Laboratory Methods for the Diagnosis of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influ-
enzae. 2nd ed. Atlanta: CDC; 2011.
40. Deghmane A, Hong E, Taha M. Emergence of meningococci with reduced susceptibility to thirdgeneration cephalosporins. J Antimicrob Chemother 2017; 72: 95-98.